A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
HealthWatch
FDA blocked melanoma drug as confusion reigned under Makary
By Arthur Allen
May 15, 2026 / 5:00 AM EDT / KFF Health News
Add CBS News on Google
Secret drug pricing deals, a virtual AI cancer clinic, and other biotech news from The Readout
The companies developing Ebvallo reached an agreement with the FDA to address its main reason for rejecting the drug.
U.S. Food and Drug Administration Commissioner Marty Makary, under pressure, defends himself in an interview with CNBC's David…
The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and…
Alzheimer's drug rollout letdown, a China-based heart drug startup, and more biotech news from The Readout
Pierre Fabre claims to now be “aligned” with U.S. regulators on the path forward for a twice-rejected treatment. Elsewhere,…
